Ferrocalm secures Holland & Barrett listing in major retail milestone

Science-backed probiotic for IBS flare-ups now available through one of the UK’s most trusted health and wellness retailers

Press Release – 16/02/2026 – Ferrocalm, the evidence-based probiotic developed to support gut health, is now available via Holland & Barrett, one of the UK’s most established and respected health and wellness retailers.

Following the brand’s recent retail expansion with Debenhams and continued growth trajectory, this latest partnership represents a significant milestone in Ferrocalm’s mission to make credible, science-backed gut-health support truly mainstream.

Consumers can now find Ferrocalm on Holland & Barrett or visit Ferrocalm.com to begin their gut-health journey.

A defining moment in the brand’s growth story

Holland & Barrett has long been synonymous with trusted health solutions across the UK. With a reputation built on quality, credibility, and consumer trust, the retailer’s endorsement marks a meaningful step forward for Ferrocalm.

For a brand founded on clinical science and transparency, this listing is more than about distribution; it’s about validation.

Since its recent rebrand and the launch of a new website, Ferrocalm has experienced a huge growth in sales, driven by increased awareness, improved accessibility, and a clear message: gut health deserves to be taken seriously.

The addition of Holland & Barrett further strengthens that momentum, placing Ferrocalm alongside some of the UK’s most recognised and respected wellness brands.

Backed by scientific research, Ferrocalm has quickly gained attention for its straightforward, no-nonsense approach: evidence over hype, empathy over jargon, and lifestyle over quick fixes.

A statement from the founder

“Partnering with Holland & Barrett is an incredibly important moment for Ferrocalm,” says Dr Jenny Bailey Cooper, Co-founder of Ferryx Ltd.

“Our mission has always been to make credible gut-health support more accessible and to help people feel confident choosing science-led solutions. Being available through a retailer with such a strong heritage in health and wellbeing reinforces everything we stand for. We’re extremely grateful to our team, our partners, and our growing community, who have helped us reach this stage.”

Bridging the gap between science and accessibility

Ferrocalm was developed by Dr Jenny Bailey Cooper, immunologist and co-founder of Ferryx Ltd, to address a specific and often overlooked challenge, providing effective probiotic support during IBS flare-ups.

Unlike many probiotics, Ferrocalm’s carefully selected bacterial strain is designed to remain stable and active even within the inflamed gut environment. The formulation is rooted in over 10 years of research and is built on scientific integrity.

As public awareness of gut health continues to grow, so too does consumer demand for products that offer genuine credibility. The probiotic category has expanded rapidly in recent years, but not all products are created equal. Ferrocalm’s positioning is clear: evidence first, transparency always.

By joining Holland & Barrett’s curated wellness offering, Ferrocalm strengthens its ability to reach a broader audience seeking trusted, research-led solutions.

“This milestone reflects a year of disciplined brand building, strategic positioning and building a clear growth strategy rooted in data and credibility. Securing a listing with Debenhams and now Holland & Barrett is a powerful validation of that work. Says Dale Graham, Chief Marketing Officer.

While obtaining a partnership with Holland & Barrett is a proud achievement for us, what matters most is the feedback from more and more customers whose lives are genuinely improving. That’s the real momentum behind the team and this brand.”

With distribution expanding and brand recognition growing, Ferrocalm’s next phase will focus on: